Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Orano Med LLC
RasCal Therapeutics, Inc.
Eli Lilly and Company
Var2 Pharmaceuticals
Massive Bio, Inc.
Apollomics Inc.
Tempus AI
Taproot Health
VitaMed Research LLC
Health Clinics Limited
SpeciCare
Leaf Vertical Inc.
INSYS Therapeutics Inc
Envita Medical Center, Inc.
Pharmacyclics LLC.